Drug information for DILTZAC

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE, EXTENDED RELEASE; ORAL 120MG Prescription AB4  DILTIAZEM HYDROCHLORIDE Diltiazem APOTEX INC 76395
CAPSULE, EXTENDED RELEASE; ORAL 180MG Prescription AB4  DILTIAZEM HYDROCHLORIDE Diltiazem APOTEX INC   "
CAPSULE, EXTENDED RELEASE; ORAL 240MG Prescription AB4  DILTIAZEM HYDROCHLORIDE Diltiazem APOTEX INC   "
CAPSULE, EXTENDED RELEASE; ORAL 300MG Prescription AB4  DILTIAZEM HYDROCHLORIDE Diltiazem APOTEX INC   "
CAPSULE, EXTENDED RELEASE; ORAL 360MG Prescription AB4  DILTIAZEM HYDROCHLORIDE Diltiazem APOTEX INC   "

Drug Adverse Effects information for DILTZAC

Role code Indications Reaction # Reports
PS ATRIAL FIBRILLATION BLOOD GLUCOSE INCREASED 1
PS ATRIAL FIBRILLATION CONVULSION 1
PS ATRIAL FIBRILLATION DYSKINESIA 1
PS ATRIAL FIBRILLATION EXAGGERATED STARTLE RESPONSE 2
PS ATRIAL FIBRILLATION HICCUPS 2
PS ATRIAL FIBRILLATION IRON BINDING CAPACITY TOTAL INCREASED 1
PS ATRIAL FIBRILLATION MUSCLE SPASMS 1
PS ATRIAL FIBRILLATION MUSCLE TWITCHING 1
PS ATRIAL FIBRILLATION MYOCLONUS 2
PS ATRIAL FIBRILLATION SENSORY DISTURBANCE 1
PS ATRIAL FIBRILLATION SERUM FERRITIN DECREASED 1
PS ATRIAL FIBRILLATION SLEEP APNOEA SYNDROME 2
PS ATRIAL FIBRILLATION STEREOTYPY 1
PS ATRIAL FIBRILLATION TRANSFERRIN SATURATION DECREASED 1
PS HYPERLIPIDAEMIA BLOOD GLUCOSE INCREASED 2
PS HYPERLIPIDAEMIA CONVULSION 2
PS HYPERLIPIDAEMIA DYSKINESIA 2
PS HYPERLIPIDAEMIA EXAGGERATED STARTLE RESPONSE 4
PS HYPERLIPIDAEMIA HICCUPS 4
PS HYPERLIPIDAEMIA IRON BINDING CAPACITY TOTAL INCREASED 2
PS HYPERLIPIDAEMIA MUSCLE SPASMS 2
PS HYPERLIPIDAEMIA MUSCLE TWITCHING 2
PS HYPERLIPIDAEMIA MYOCLONUS 4
PS HYPERLIPIDAEMIA SENSORY DISTURBANCE 2
PS HYPERLIPIDAEMIA SERUM FERRITIN DECREASED 2
PS HYPERLIPIDAEMIA SLEEP APNOEA SYNDROME 4
PS HYPERLIPIDAEMIA STEREOTYPY 2
PS HYPERLIPIDAEMIA TRANSFERRIN SATURATION DECREASED 2
PS PRODUCT USED FOR UNKNOWN INDICATION BLOOD GLUCOSE INCREASED 1
PS PRODUCT USED FOR UNKNOWN INDICATION CONVULSION 1
PS PRODUCT USED FOR UNKNOWN INDICATION DYSKINESIA 1
PS PRODUCT USED FOR UNKNOWN INDICATION EXAGGERATED STARTLE RESPONSE 2
PS PRODUCT USED FOR UNKNOWN INDICATION HICCUPS 2
PS PRODUCT USED FOR UNKNOWN INDICATION IRON BINDING CAPACITY TOTAL INCREASED 1
PS PRODUCT USED FOR UNKNOWN INDICATION MUSCLE SPASMS 1
PS PRODUCT USED FOR UNKNOWN INDICATION MUSCLE TWITCHING 1
PS PRODUCT USED FOR UNKNOWN INDICATION MYOCLONUS 2
PS PRODUCT USED FOR UNKNOWN INDICATION SENSORY DISTURBANCE 1
PS PRODUCT USED FOR UNKNOWN INDICATION SERUM FERRITIN DECREASED 1
PS PRODUCT USED FOR UNKNOWN INDICATION SLEEP APNOEA SYNDROME 2
PS PRODUCT USED FOR UNKNOWN INDICATION STEREOTYPY 1
PS PRODUCT USED FOR UNKNOWN INDICATION TRANSFERRIN SATURATION DECREASED 1
PS SUPRAVENTRICULAR TACHYCARDIA BLOOD GLUCOSE INCREASED 1
PS SUPRAVENTRICULAR TACHYCARDIA CONVULSION 1
PS SUPRAVENTRICULAR TACHYCARDIA DYSKINESIA 1
PS SUPRAVENTRICULAR TACHYCARDIA EXAGGERATED STARTLE RESPONSE 2
PS SUPRAVENTRICULAR TACHYCARDIA HICCUPS 2
PS SUPRAVENTRICULAR TACHYCARDIA IRON BINDING CAPACITY TOTAL INCREASED 1
PS SUPRAVENTRICULAR TACHYCARDIA MUSCLE SPASMS 1
PS SUPRAVENTRICULAR TACHYCARDIA MUSCLE TWITCHING 1
PS SUPRAVENTRICULAR TACHYCARDIA MYOCLONUS 2
PS SUPRAVENTRICULAR TACHYCARDIA SENSORY DISTURBANCE 1
PS SUPRAVENTRICULAR TACHYCARDIA SERUM FERRITIN DECREASED 1
PS SUPRAVENTRICULAR TACHYCARDIA SLEEP APNOEA SYNDROME 2
PS SUPRAVENTRICULAR TACHYCARDIA STEREOTYPY 1
PS SUPRAVENTRICULAR TACHYCARDIA TRANSFERRIN SATURATION DECREASED 1
Ads by Google